Search

Your search keyword '"Ezzedine, Khaled"' showing total 1,187 results

Search Constraints

Start Over You searched for: Author "Ezzedine, Khaled" Remove constraint Author: "Ezzedine, Khaled"
1,187 results on '"Ezzedine, Khaled"'

Search Results

1. Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo.

Catalog

Books, media, physical & digital resources

6. Methodological innovations and stakeholder involvement in core outcome sets for skin diseases: a survey of the C3 working groups

9. Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey study

10. Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1

12. Clinical relevance and uptake of core outcome sets in dermatology

17. Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial

18. Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo

19. Sun exposure and protection habits: Self‐reported attitudes, knowledge and behaviours.

20. Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice

21. Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients

24. Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses.

26. Estimating the burden of vitiligo: a systematic review and modelling study

28. 501 - Efficacy and safety of upadacitinib in a phase 2 randomized, double-blind, dose-ranging study of adults with extensive non-segmental vitiligo

31. Efficacy Comparison of Targeted Systemic Monotherapies Including Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: a Network Meta-Analysis

32. Incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream.

34. Navigating the landscape of core outcome set development in dermatology

39. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm

40. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations

41. Clinician‐reported outcome measures for the assessment of vitiligo: A scoping review

45. Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo

46. Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm

47. Vitiligo Patient Population and Disease Burden in France: VIOLIN Study Results From the CONSTANCES Cohort

50. Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study